Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1768-1775

  Zidovetzki, Raphael ^a   Wang, Jin Lin ^b   Kim, Jeong A ^b   Chen, Peijia ^b   Fisher, Mark ^b   Hofman, Florence M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Brain; cAMP; Endothelin; Endothelium; Plasminogen activator inhibitor 1; Protein kinase C

Indexed keywords

CYCLIC AMP; ENDOTHELIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C;

ARTICLE; BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VASCULAR ENDOTHELIUM;

EID: 0033002258     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1768     Document Type: Article

References (78)

1. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 1990;88:614-618.
2. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, Sokolovsky, M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke. 1997;28:1951-1954.
3. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet. 1989;2:1402.
4. Suzuki H, Sato S, Suzuki Y, Takekoshi K, Ishihara N, Shimoda S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand. 1990;81:553-554.
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
6. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.
7. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Presser effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-9800.
8. Galron R, Kloog Y, Bdolah A, Sokolovsky M. Functional endothelin/ sarafotoxin receptors in rat heart myocytes: structure-activity relationships and receptor subtypes. Biochem Biophys Res Commun. 1989; 163:936-943.
9. Fukuda Y, Hirata Y, Yoshimi H, Kojima T, Kobayashi Y, Yanagisawa M, Masaki T. Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem Biophys Res Commun. 1988;155:167-172.
10. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
11. Masaki T, Vane JR, Vanhoutte PM. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev. 1994;46:137-142.
12. Mac Cumber MW, Ross CA, Snyder SH. Endothelin in brain: receptor, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A. 1990;87:2359-2363.
13. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990; 348:730-732.
14. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992;13:103-108.
15. Takayanagi R, Kitazumi K, Takasaki C, Ohnaka K, Aimoto S, Tasaka K, Ohashi M, Nawata H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 1991;282:103-106.
16. Emori T, Hirata Y, Kanno K, Ohata K, Eguchi S, Imai T, Schichiri M, Marumo F. Endothelin-3 stimulates production of endothelium-derived nitric oxide via phosphoinositide breakdown. Biochem Biophys Res Commun. 1991;174:228-235.
17. Miller RC, Pelton JT, Huggins JP. Endothelins - from receptors to medicine. Trends Pharmacol Sci. 1993;14:54-60.
18. Stanimirovic DB, Yamamoto T, Uematsu S, Spatz M. Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J Neurochem. 1994;62:592-601.
19. Eguchi S, Kozuka M, Hirose S, Ito T, Hirata Y, Marumo F, Hagiwara H. Identification of G-protein-coupled endothelin receptors in cultured bovine endothelial cells. Biochem Biophys Res Commun. 1991;174: 1343-1346.
20. 2+ mobilization in smooth muscle cell. Biochem Biophys Res Commun. 1989;160: 758-764.
21. Ladoux A, Frelin C. Endothelins inhibit adenylate cyclase in brain capillary endothelial cells. Biochem Biophys Res Commun. 1991;180: 169-173.
22. Gardner JP, Tokudome G, Tomonari H, Maher E, Hollander D, Aviv A. Endothelin-induced calcium responses in human vascular smooth muscle cells. Am J Physiol. 1992;262:C148-C155.
23. Plow EF, Merren T, Redlitz A, Mills LA, Hoover-Plow JL. The cell biology of the plasminogen system. FASEB J. 1995;9:939-945.
24. Hekman CM, Loskutoff DJ. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. Arch Biochem Biophys. 1988;262:199-210.
25. Loskutoff DJ, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor. Prog Hemostasis Thromb. 1989;9:87-115.
26. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood. 1987; 69:381-387.
27. Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J. Regulation of PAI-1 gene expression in vivo. Thromb Haemostasis. 1993;70:135-137.
28. Hamsten A, Wiman B, de Faire, U, Blomback M. Increased plasma levels of a rapid inhibitor of myocardial infarction. N Engl J Med. 1985;313: 1557-1563.
29. Gram J, Jespersen J, Kluft C, Rijken DC. On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction. Acta Med Scand. 1987;221:149-153.
30. Wiman B, Ljungberg B, Chmielewska J, Urden G, Blomback M, Johnsson H. The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med. 1985;105:265-270.
31. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A. 1992;89:6998-7002.
32. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb. 1993;13:1090-1100.
33. Schleef RR, Loskutoff DJL. Fibrinolytic system of vascular endothelial cells. Haemostasis. 1988;18:328-341.
34. Van Mourik JA, Lawrence DA, Loskutoff DJ. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem. 1984;259:14914-14921.
35. Levin EG, Marzec U, Anderson J, Harker LA. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest. 1984;74:1988-1995.
36. Heaton JH, Dame MK, Gelehrter TD. Thrombin induction of plasminogen activator, inhibitor mRNA in human umbilical vein endothelial cells in culture. J Lab Clin Med. 1992;120:222-228.
37. Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J Lab Clin Med. 1987;109:97-104.
38. Crutchley DJ, Conanan LB. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J Biol Chem. 1986;261:154-159.
39. Santell L, Levin EG. Cyclic AMP potentiates phorbol ester stimulation of tissue, plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. J Biol Chem. 1988;263:16802-16808.
40. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411-452.
41. Hofman FM, Dohadwala MH, Wright AD, Hinton DR, Walker SM. Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol. 1994;54:19-24.
42. Yamamoto C, Kaji T, Sakamoto M, Kozuka H. Modulation by endothelin-1 of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells: interaction of endothelin-1 with cytokines. Biol Pharm Bull. 1993;16: 714-715.
43. Rydholm H, Boström S, Eriksson E, Risberg B. Complex intracellular signal transduction regulates tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) synthesis in cultured human umbilical vein endothelium. Scand J Clin Lab Invest. 1990;55: 323-330.
44. Iwamoto T, Tamaki K, Nakayama M, Okuda S, Fujishima M. Effect of endothelin 1 on fibrinolysis and plasminogen activator inhibitor 1 synthesis in rat mesangial cells. Nephron. 1996;73:273-279.
45. Bar RS, Boes M, Dake BL, Booth BA, Henley SA, Sandra A. Insulin, insulin-like, growth factors, and vascular endothelium. Am J Med. 1988; 85:59-70.
46. Boes M, Dake BL, Bar RS. Interactions of cultured endothelial cells with TGF-β, bFGF, PDGF, and IGF-1. Life Sci. 1991;48:811-821.
47. Beitz JG, Kim I-S, Calabresi P, Fraskelon AR. Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci U S A. 1991;88:2021-2025.
48. Dupuy E, Bikfalvi A, Rendu F, Toledano SL, Tobelem G. Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels. Exp Cell Res. 1991;185:363-372.
49. Kollros PR, Konkle BA, Ambarian AP, Henrikson P. Plasminogen activator inhibitor-1 expression by brain microvessel endothelial cells is inhibited by elevated glucose. J Neurochem. 1994;63:903-909.
50. Doctrow SR, Folkman J. Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens. J Cell Biol. 1987;104:679-687.
51. Maher PA. Stimulation of endothelial cell proliferation by vanadate is specific for microvascular endothelial cells. J Cell Physiol. 1992;151: 549-554.
52. Eguchi S, Hirata Y, Imai T, Marumo F. Endothelin receptor subtypes are coupled, to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature. Endocrinology. 1993;132:524-529.
53. Aramori I, Nakanishi S. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem. 1992;267:12468-12474.
54. Martin P, Delumeau JC, Durieu-Trautmann O, Le Nguyen D, Premont J, Strosberg AD, Couraud PO. Are several G proteins involved in the different effects of endothelin-1 in mouse striatal astrocytes? J Neurochem. 1991;56:1270-1275.
55. Couraud PO, Durieu-Trautmann O, Le Nguyen D, Marin P, Gilbert F, Strosberg AD. Functional endothelin-1 receptors in rat astrocytoma C6. Eur J Pharmacol. 1991;206:191-198.
56. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T. A novel, vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem. 1989;264: 7856-7861.
57. Iwai M, Hasegawa M, Taii S, Sagawa N, Nakao K, Imura H, Nakanishi S, Mori T. Endothelins inhibit luteinization of cultured porcine granulosa cells. Endocrinology. 1991;129:1909-1914.
58. Tomita K, Nonoguchi H, Marumo F. Effects of endothelin on peptide-dependent cyclic adenosine monophosphate accumulation along the nephron segments of the rat. J Clin Invest. 1990;185:2014-2018.
59. Thiemermann C, Lidbury PS, Thomas GR, Vane JR. Endothelin inhibits ex vivo platelet aggregation in the rabbit. Eur J Pharmacol. 1988;158: 181-185.
60. Simonson MS, Dunn MJ. Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation. J Clin Invest. 1990;85: 790-797.
61. Sugiura M, Inagami T, Harem GMT, Johns JA. Endothelin action: inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun. 1989;158:170-176.
62. Ohlstein EH, Horohonich S, Hay DWP. Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther. 1989;250:548-555.
63. Vigne P, Lazdunski M, Frelin C. The inotropic effect of endothelin-1 on rat atria involves hydrolysis of phosphatidylinositol. FEBS Lett. 1989; 249:143-146.
64. 2+ uptake activated by endothelins in rat brain endothelial cells. Eur J Pharmacol. 1994;288:1-8.
65. Slivka SR, Loskutoff DJ. Regulation of type 1 plasmonogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim Biophys Acta. 1991;1094:317-322.
66. Francis RB, Neely S. Inhibition of endothelial secretron of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP. Biochim Biophys Acta. 1989;1012: 207-213.
67. Fukao H, Matsumoto H, Ueshima S, Okada K, Matsuo O. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C. Life Sci. 1995;57:1267-1276.
68. Muldoon L, Rodland KD, Forsythe ML, Magun BE. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. J Biol Chem. 1989;264:8529-8536.
69. van der Bend RL, de Widt J, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D: comparison with the response to endothelin. Biochem J. 1992;285:235-240.
70. 2+ mobilization in smooth muscle cells by protein kinase C. Am J Physiol. 1994;266:C1560-C1567.
71. A receptor via influx of calcium and is independent of protein kinase C. Hypertension. 1995;26:1035-1040.
72. Shubeita HE, Martinson EA, Van Bilsen M, Chien KR, Brown JH. Proc Natll Acad Sci U S A. 1992;89:1305-1309.
73. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989;337:661-663.
74. Mattila P, Majuri ML, Mattila PS, Renkonen R. TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand J Immunol. 1992;36:159-165.
75. Meichle A, Schutze S, Hensel G, Brunsing D, Kronke M. Protein kinase. C-independent activation of nuclear factor kappa B by tumor necrosis factor. J Biol Chem. 1990;265:8339-8343.
76. Ritchie AJ, Johnson DR, Ewenstein BM, Pober JS. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivalion: studies with phorbol myristate acetate and staurosporine. J Immunol. 1991;146:3056-3062.
77. Konkle BA, Kollros PR, Kelly MD. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways. J Biol Chem. 1990;265:21867-21873.
78. Sitter, T, Toet K, Fricke, H, Schiffl H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol. 1996;271:R1256-R1263.